Italia markets closed

Monte Rosa Therapeutics, Inc. (GLUE)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
5,33-0,12 (-2,20%)
Alla chiusura: 04:00PM EDT
5,25 -0,08 (-1,50%)
Dopo ore: 06:37PM EDT
Schermo intero
Caricamento grafico interattivo in corso...
  • GlobeNewswire

    Monte Rosa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update

    On track to present initial data from Phase 1/2 clinical trial of MRT-2359 for MYC-driven solid tumors in the second half of 2023Received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for MRT-2359 for the treatment of small cell lung cancer (SCLC)Announced development candidate MRT-6160, a novel, highly selective molecular glue degrader of VAV1, with IND submission expected 1H 2024Strong cash position expected to sustain operations into 2025 and enable advancement of p

  • GlobeNewswire

    Monte Rosa Therapeutics Appoints Dr. Anthony M. Manning to Board of Directors

    BOSTON, July 26, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the appointment of Anthony M. Manning, Ph.D., to its Board of Directors. Dr. Manning is a highly accomplished drug discovery leader in the field of autoimmune and inflammatory diseases. ”Dr. Manning brings extensive knowledge and experience in the field of immunology and inflammation to our B

  • GlobeNewswire

    Monte Rosa Therapeutics to Present at Upcoming Investor and Industry Conferences

    BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the company is scheduled to present at the following investor and industry events in June: BIO International Healthcare Conference in Boston; panel entitled “From Serendipity to Rational Design, Redefining the Rules of Molecular Glue Discovery” on June 5 at 1PM ET in Session Room 208Jefferies